Synonyms: Brenzavvy® | compound 29 [PMID: 21737266] | EGT-0001442 | EGT-1442 | EGT1442 [6] | THR-1442
bexagliflozin is an approved drug (FDA (2023))
Compound class:
Synthetic organic
Comment: Bexagliflozin is an oral sodium-glucose cotransporter 2 (SGLT2; SLC5A2) inhibitor [5], that was developed for its ability to improve control of blood glucose levels for the treatment of type 2 diabetes [1,6]. It is a C-aryl glucoside class molecule.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Bexagliflozin is ~2400-fold selective for SGLT2 compared to SGLT1 in vitro [5]. |
Selectivity at transporters | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|